| IDORSIA AG SF-,05 |
| Schweiz |
| Gesundheit |
| CH0363463438 / A2DTEB |
| 19T (Frankfurt) |
| FRA:19T, ETR:19T, 19T:GR |
| - |
| https://www.idorsia.com/ |
|
Idorsia Ltd. is a Swiss-based biopharmaceutical co..
>Volltext.. |
| 1090.79 Mio. EUR |
| 2371.22 Mio. EUR |
| 249.7 Mio. EUR |
| -128.89 Mio. EUR |
| -126.66 Mio. EUR |
| -0.61 EUR |
| 1358.48 Mio. EUR |
| 68.53 Mio. EUR |
| -192.83 Mio. EUR |
| 0.47 |
| 232.36% |
| 57.92% |
| - |
| - |
| - |
| - |
| IDORSIA |
| 08.01.26 |
|
||||
|
||||
|
||||
|